In this podcast, Dr. Fay Hlubocky and Dr. Manali Patel discuss what health equity and quality care mean in the context of cancer care and describe research highlights in these areas from the 2022 Quality Care Symposium.
Read research from the December 2022 session of the ASCO Plenary Series, which explores combining immunotherapy for advanced non-small cell lung cancer with high PD-L1.
In this podcast, Dr. Xiuning Le discusses research from the 2022 North America Conference on Lung Cancer, including 3 studies evaluating targeted therapy treatments for people with non-small cell lung cancer.
Drs. David Ilson, Sumanta (Monty) Pal, and Tian Zhang discuss new research presented at the 2022 ESMO Congress, including studies about treating liver, colorectal, stomach, kidney, bladder, and prostate cancers.
Read research from the 2022 ASCO Quality Care Symposium, including studies on how cancer navigation programs and lower-cost drug alternatives can lower the cost of care and a study on how Medicaid expansion affected the rates of metastatic cancer diagnoses and cancer deaths.
In this podcast, 3 Cancer.Net Associate Editors discuss new research presented at the 2022 ASCO Annual Meeting in non-small cell lung cancer, non-Hodgkin lymphoma, Ewing sarcoma, and neuroblastoma.
Dr. Manali I. Patel discusses what people with cancer should know about getting access to advances presented at scientific meetings, including questions to ask your health care team, why access to new advances may not be available right away, and how to get involved with cancer research.
In this podcast, Dr. Maryam Lustberg discusses 3 themes from the 2022 Multinational Association of Supportive Care in Cancer (MASCC) Annual Meeting, including insights on disparities in access to supportive care, the impacts of COVID-19 on the delivery of supportive care, and clinician burnout.
In this podcast, 3 Cancer.Net Associate Editors discuss new research presented at the 2022 ASCO Annual Meeting in head and neck cancer, brain tumors, and health equity.
Read research from the August 2022 session of the ASCO Plenary Series, which features a study that evaluated how common it is for people with lung cancer to have inherited genetic mutations known to increase cancer risk.
